The Efficacy of Vitamin A Supplement in the Treatment of Scabies

Authors

  • Marwan S.M. Al-Nimer Department of Pharmacology, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq
  • Eman M. Tawfiq Department of Clinical Pharmacy, the Ramadi General Hospital, Anbar, Iraq
  • Zeyad T. Abdulhadi Department of Medicine, Dermatology, College of Medicine, Anbar University, Anbar, Iraq
  • Thamer A. Hameed Department of Medicine, Dermatology, College of Medicine, Anbar University, Anbar, Iraq

DOI:

https://doi.org/10.37591/rrjom.v5i1.1488

Abstract

 

Scabies is a debilitating contagious parasitic skin disease caused by a tiny mite (Sarcoptes scabiei) treated with the acaricides. Vitamin A supplementation is indicated in management of parasitic infestations in human. This study aimed to assess the effect of vitamin A supplementation as "add on therapy" on the cure rate and quality of life (Qol) in scabies patients treated either with permethin or benzyl benzoate lotions. A total number of 120 patients (66 males and 54 females), their ages ranged from 3 to 82 years were enrolled in this study. The clinical symptoms and signs were assessed according to their severity, location, lesion types and numbers. The severity of pruritis assessed by visual analogue scores (VAS). The Arabic version of Dermatology Life Quality Index for children and adults was applied to assess the impact of scabies on (QoL). Patients randomly sub-grouped to receive a single dose of 2500 IU vitamin A supplement to one application permethin lotion (5%) or two applications benzyl benzoate lotion (25%) and were followed-up for one week. Vitamin A supplementation improve the cure rate non-significantly in patients treated with permethin lotion (86.7% versus 66.7%, p > 0.05) whereas reached  to the significant level in patients treated with  benzyl benzoate lotion (76.7% versus 43.3%, p < 0.01), respectively. Permethin reduced the mean of total Qol scores in adult by 43.8% and after using vitamin A to 35.1% while benzyl benzoate reduced the mean scores in children by 40.6% and by 34.4% after using vitamin A. It concludes that vitamin A as an "add on therapy", in scabies, is a promising way to improve the cure rate and the quality of life within short period.

 

Keywords: Scabies, vitamin A, cure rate, quality of life

Scabies is a debilitating contagious parasitic skin disease caused by a tiny mite (Sarcoptes scabiei) treated with the acaricides. Vitamin A supplementation is indicated in management of parasitic infestations in human. This study aimed to assess the effect of vitamin A supplementation as "add on therapy" on the cure rate and quality of life (Qol) in scabies patients treated either with permethin or benzyl benzoate lotions. A total number of 120 patients (66 males and 54 females), their ages ranged from 3 to 82 years were enrolled in this study. The clinical symptoms and signs were assessed according to their severity, location, lesion types and numbers. The severity of pruritis assessed by visual analogue scores (VAS). The Arabic version of Dermatology Life Quality Index for children and adults was applied to assess the impact of scabies on (QoL). Patients randomly sub-grouped to receive a single dose of 2500 IU vitamin A supplement to one application permethin lotion (5%) or two applications benzyl benzoate lotion (25%) and were followed-up for one week. Vitamin A supplementation improve the cure rate non-significantly in patients treated with permethin lotion (86.7% versus 66.7%, p > 0.05) whereas reached  to the significant level in patients treated with  benzyl benzoate lotion (76.7% versus 43.3%, p < 0.01), respectively. Permethin reduced the mean of total Qol scores in adult by 43.8% and after using vitamin A to 35.1% while benzyl benzoate reduced the mean scores in children by 40.6% and by 34.4% after using vitamin A. It concludes that vitamin A as an "add on therapy", in scabies, is a promising way to improve the cure rate and the quality of life within short period.

 

Keywords: Scabies, vitamin A, cure rate, quality of life

Cite this Article

Marwan S.M. Al-Nimer, Eman M Tawfiq, Zeyad T. Abdulhadi, et al. The Efficacy of Vitamin A Supplement in the Treatment of Scabies; Research & Reviews: Journal of Medicine 2015; 5(1): 19–26p.

Downloads

Published

2019-05-01

Issue

Vol. 5 No. 1 (2015)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.